CDK4 and colorectal carcinoma: With the aim of elucidating metabolic adaptive responses and the emergence of potential vulnerabilities consequent to CDK4/6 depletion or inhibition, we targeted CDK4/6 in HCT116 human colorectal carcinoma cells by using specific small interference (si) RNAs.